API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://johnsonandjohnson.gcs-web.com/static-files/4120e707-3112-4f0b-a1d2-7015893e855c
https://news.bms.com/news/details/2023/The-Bristol-Myers-Squibb-Janssen-Collaboration-Launches-Pivotal-Phase-3-Librexia-Clinical-Trial-Program-Evaluating-Milvexian-an-Investigational-Oral-Factor-XIa-Inhibitor/default.aspx
https://www.fiercepharma.com/pharma/johnson-johnson-ceo-duato-points-out-5-pipeline-meds-can-generate-5b